Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Patient monitoring device in a hospital room

Jun 12, 2026

Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform

Danaher has finalized its acquisition of Masimo, integrating the company into its Diagnostics segment, which marks a significant shift in the patient monitoring landscape.This $9.5 billion cash deal ends Masimo's tenure as an independent public entity and introduces a new governance structure under Danaher. As a result, Masimo's shares have been delisted from Nasdaq, transitioning from a standalone equity story to one embedded within Danaher's broader diagnostics platform. This integration could
A stethoscope on a medical chart in a clinical office setting

Jun 12, 2026

Dassault Systèmes SE Stock (FR0014003TT8): Partnership In Focus After PariSanté Campus Deal

Dassault Systèmes has announced a partnership with PariSanté Campus aimed at fostering AI-driven healthcare startups across Europe, although its stock remains under pressure in the market.The collaboration with PariSanté Campus, a French digital health hub, is designed to enhance the ecosystem for AI and digital innovation in healthcare. The partnership will provide selected startups access to Dassault Systèmes' platforms, including virtual twin technologies and AI tools, to facilitate the devel
A minimalist illustration of a nanomagnetic AI chip and a rocket in a dark color scheme.

Jun 12, 2026

RKTO Stock Jumps As Rocket One Pivots From Biotech To Space AI

Rocket One Inc. is undergoing a significant transformation, shifting from a biotech focus to the burgeoning space AI sector, as evidenced by its rebranding and new ticker symbol RKTO on Nasdaq.The company, formerly known as Hoth Therapeutics, is strategically pivoting to concentrate on the space economy, particularly through an exclusive license for nanomagnetic AI chip technology. This technology aims to create ultra-low-power chips suitable for orbital and defense applications, addressing chal
Minimalist illustration of a drug compound

Jun 12, 2026

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

Dr. Jennifer Bath, CEO of MindWalk, will participate in a virtual panel on AI-driven drug discovery, alongside Absci and a leading AI compute provider, during Jones AI Day on June 15, 2026.The panel, titled “Partnering to Power the New Era of Drug Discovery,” will delve into how advancements in high-performance computing and generative AI can overcome traditional obstacles in drug development. This includes addressing long screening timelines and tackling historically challenging targets. Modera
A training manual and coffee cup in a dimly lit office during blue hour.

Jun 12, 2026

Skillet Launches AI Commercial Excellence Platform for Pharmaceutical & Medtech Teams

Skillet has unveiled an AI-driven commercial excellence platform designed specifically for the life sciences sector, marking its entrance from stealth mode. This innovative platform aims to enhance the training and preparation of sales teams in pharmaceuticals and medical devices.Developed by Wayground, Skillet offers a suite of AI tools that includes roleplay simulations, coaching for managers, and call preparation features tailored to the unique challenges faced by sales representatives. Early
A minimalist representation of a clinical trial document with a checkmark in a dark color scheme.

Jun 12, 2026

Astellas taps AI to reshape clinical programs as rising stars emerge

Astellas Pharma is actively transforming its drug development strategy by internalizing clinical operations and leveraging AI technologies to enhance efficiency.The company, under the leadership of Tadaaki Taniguchi, is moving away from outsourcing by establishing a dedicated team to manage the entire lifecycle of each asset. This shift allows Astellas to conduct trials with its own research teams, significantly speeding up processes and improving communication across its global operations. AI p
A vial of biologic drug on a lab bench with pharmaceutical packaging in a laboratory setting.

Jun 12, 2026

Driven By Innovation, Biologics And AI, India’s Pharma Market May More Than Double To USD 130 Billion By 2030: ASSOCHAM

India's pharmaceutical market is on a trajectory for significant growth, with projections indicating a potential increase to between USD 120 billion and USD 130 billion by 2030, up from an estimated USD 55 billion in 2025.This anticipated surge is largely attributed to advancements in biologics and the integration of artificial intelligence within the industry. As the sector evolves, pharmaceutical exports, which reached USD 30 billion in 2024-25, are also expected to see remarkable growth, pote
Flat illustration of a herbal remedy leaf

Jun 12, 2026

FuDe debuts at the 2026 London Tech Week, showcasing a new preventative health management paradigm.

Beijing Xutang Biotech made a significant entry at London Tech Week 2026, introducing its innovative health management platform, FuDe, which merges traditional Chinese medicine (TCM) with advanced AI technology.This year’s London Tech Week has attracted over 30,000 participants, focusing on sectors such as AI, quantum computing, and notably, life sciences. A highlight has been the Deep Tech Stage, where FuDe's introduction has drawn considerable attention. The platform aims to address the widesp
A molecular model on a lab bench with simulation data papers in a dimly lit laboratory.

Jun 12, 2026

AI model accelerates molecular simulations by 10,000-fold

A new AI framework, TITO, has been introduced, promising to revolutionize molecular simulations by accelerating them by up to 10,000 times. This advancement, published in *Science Advances*, leverages deep generative modeling to learn the statistical rules of molecular motion from existing simulation data.Traditional molecular dynamics simulations operate on a timescale of approximately one femtosecond, which leads to extensive computational demands for processes relevant to drug development. TI
An open book of scientific literature on a wooden desk in a dimly lit study room.

Jun 12, 2026

Rockefeller University Press Collaborates with Cashmere to Enhance Responsible AI Discoverability

Rockefeller University Press (RUP) has announced a significant partnership with Cashmere, aimed at integrating AI technologies with its extensive collection of peer-reviewed scientific literature. This collaboration seeks to establish a robust framework for AI inference, ensuring that AI systems utilize credible and ethically sourced data, which is crucial for applications in the life sciences.The partnership addresses a pressing need for transparency and integrity in AI applications, particular
An office desk with financial documents and a coffee cup, representing dealer intelligence application.

Jun 12, 2026

AI risk intelligence startup Privue raises angel round to expand dealer intelligence application

Privue, an AI-driven risk intelligence startup, has successfully secured angel funding to enhance its dealer intelligence application, targeting sectors such as pharma and MedTech.Based in Gurugram, Privue aims to leverage this funding to bolster its AI capabilities and expand its market reach. The startup, founded by Saurabh Verma and Snehil Vijay, is focused on transforming disparate data sources—like credit bureau records and financial filings—into predictive insights that assist financial le
Flat illustration of a data source and analytics application

Jun 12, 2026

Privue Secures Angel Funding to Revolutionize AI Risk Intelligence in Enterprises

Privue, a startup specializing in AI-driven risk intelligence, has secured angel funding to enhance its market capabilities.The funding round, backed by notable investors from various sectors including manufacturing and insurance, aims to strengthen Privue's AI technologies and expand its reach in industries such as pharmaceuticals, MedTech, and chemicals. Founded by Saurabh Verma and Snehil Vijay, the company has created an innovative AI risk analytics application designed to transform disparat